Cartesian Therapeutics, Inc. - COM NEW (RNAC)

Historical Portfolio Holders from Q1 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
6.87M
Holdings value Q3 2024
$110M
Value change Q3 2024
+$42.9M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
61
Number of buys Q3 2024
30
Number of sells Q3 2024
-20
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 6.87M $110M +$42.9M $16.12 61
2024 Q2 3.27M $88.3M +$88.1M $27.01 57
2024 Q1 1.86K $1.16K +$1.16K $0.64 4
2023 Q4 0 $0 -$1.27K 0
2023 Q3 1.2K $1.27K $0 $1.06 1
2023 Q2 1.2K $1.34K $0 $1.12 1
2023 Q1 1.2K $1.67K $0 $1.39 1